Chief Executive’s blog: November 2018

Chief Executive’s blog: November 2018

“We are doing our utmost to ensure that DHSC is fully aware of the impact that the stockpiling of medicines will have on supply and prices”

By PSNC Chief Executive Simon Dukes

Despite dominating politics and the headlines now for years (literally), I am not going to apologise for adding to the tens of millions of words written about Britain’s exit from the EU.

Although a draft Brexit Agreement is now on the table in London and Brussels, clearly we still have a long way to go until (if?) the deal is agreed by the EU27 and passed by the British Parliament.

Quite rightly a lot of community pharmacists and LPCs are concerned about Brexit and the impact it will have on patients, communities and of course businesses. I share your concerns.

From a medicine supply perspective, an agreed deal is essential if we are to reduce the negative impact of a chaotic exit from the European Union.

PSNC will continue to work with officials at the Department of Health and Social Care (DHSC) to help minimise disruption from a no-deal Brexit. Stephen Barclay, from his time at DHSC, will be better briefed than most about Brexit-related medicine supply issues. We wish him well in his new role as the third Brexit Secretary in under five months, and I look forward to meeting his successor at DHSC, Stephen Hammond, in due course.

We are doing our utmost to ensure that DHSC is fully aware of the potential ramifications of a no-deal, and moreover the impact that the stockpiling of medicines will have on supply and prices.

We have stated clearly to DHSC that community pharmacies need to have the ability to exercise appropriate professional discretion to ensure the continuity of an alternative equivalent medicine to patients in accordance with patient need.

Furthermore, we need to have expeditious reimbursement for additional costs and appropriate regulatory and practical support, to ensure medicine supplies to patients. You can see a full list of PSNC requirements of HM Government on our dedicated webpage: – where we will also be providing regular updates over the coming weeks.

As you would expect, PSNC is working collaboratively with other national pharmacy bodies (particularly the NPA, CCA, AIM, RPS and PDA) as well as organisations across the medicines supply chain to secure the best possible contingency plan for community pharmacies and their patients.

On other business, the PSNC Committee held its annual planning meeting last week in Birmingham. We will write-up the outcomes and fold these into our strategy for 2019 and beyond; I look forward to sharing the details with you in the next edition of my blog.

More New Blog Posts >